Rab13, Proteintech, 11718-1-AP

Proteintech 11718-1-AP · Rab13 · pAb · Rabbit
3.33
(Overall rating from 1 review)
#6 of 13 targeting Rab13
3.33
From 1 review · #6 of 13 for Rab13

Information about this antibody

Target
Catalog No
11718-1-AP
Application
N/A
Clonality
pAb
Origin
Rabbit
Reactivity
N/A
Conjugation
N/A
Product Link
N/A

Vendor notes

No vendor notes available for this antibody.

pAbmAbs Average Ratings

ℹ
Western Blot
4.27
Immunostaining
3.18
IP
2.20
Overall
3.33

User Reviews (1)

Review of: Rab13, Proteintech, 11718-1-AP by pAbmAbs Data Mining

Reviewed: May 8, 2026

Our team has carried out deep research in the published scientific literature to identify papers and reports using antibodies directed against human Rab13 and followed up by extraction and evaluation of the available data to assess its performance according to pAbmAbs rating criteria.

YCharOS is here conducting a large head-to-head study comparing 11 commercial research antibodies against human Rab13

The antibody panel was evaluated across multiple applications. For Western blotting (WB), HEK-293T WT and RAB13 KO lysates (30 µg protein) as well as U-87 MG WT and RAB13 KD lysates (40 µg protein) were analyzed. U-87 MG lysates were used for immunoprecipitation (IP), while U-87 MG control and RAB13 KD cells were used for immunofluorescence (IF).

In WB (1:500 ab dilution) using U-87 MG 11718-1-AP detected a band of appr. 24 kDa in control cell lysate with no corresponding band observed in KD cell lysate. A band was detected following IP (2 µg Ab used), this band had same intensity compared to bands in input extract (4% of starting material) and immunodepleted extract (4% of total unbound fraction), showing that the antibody does not deplete the antigen from cell lysate. In IF (1:1000 ab dilution), comparable staining intensities was observed in both KD and WT cells.

We highly encourage other scientists to share their observations.

Western Blot
Immunostaining
IP

Submit Your Review of Rab13, Proteintech, 11718-1-AP

Please log in to submit a review.